Primary Bronchial Hybrid Low‐Grade Fibromyxoid Sarcoma/Sclerosing Epithelioid Fibrosarcoma With EWSR1::CREB3L1 Fusion: Diagnostic Insights From a Challenging Case in the Respiratory Tract
Pathology International · 2026
DOI: 10.1111/pin.70185 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathology International, 2026. Verfasst von Hiroko Ikeda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan. Hauptthemen laut MEDLINE: Fibrosarcoma, Bronchial Neoplasms, RNA-Binding Protein EWS, Cyclic AMP Response Element-Binding Protein. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hybrid low‐grade fibromyxoid sarcoma/sclerosing epithelioid fibrosarcoma (LGFMS/SEF) is an ultra‐rare fibroblastic sarcoma that typically arises in the soft tissues. Primary involvement of the respiratory tract is extremely uncommon, and, to our knowledge, no cases arising in the bronchial wall have previously been reported. We describe a hybrid LGFMS/SEF arising in the right bronchus of a Japanese woman in her 40 s. The 2‐cm tumor was incidentally detected, and imaging studies demonstrated no other lesions. Histologically, the tumor consisted predominantly of bland spindle cells within fibromyxoid stroma with collagen rosettes, admixed with epithelioid fibroblasts arranged in cords. Immunohistochemically, the tumor showed diffuse positivity for MUC4. Comprehensive genomic profiling performed for diagnostic purposes identified an EWSR1::CREB3L1 fusion gene, supporting the diagnosis of hybrid LGFMS/SEF. Retrospective review of the transbronchial biopsy specimen revealed subtle spindle cells showing MUC4 expression by immunohistochemistry and EWSR1 rearrangement by fluorescence in situ hybridization, which had initially been interpreted as inflammatory change. This case highlights important diagnostic pitfalls of hybrid LGFMS/SEF and provides the clinicopathological insights into EWSR1::CREB3L1 ‐associated fibroblastic sarcoma arising in the bronchial wall.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.
- Department of Thoracic Surgery, Kanazawa University, Kanazawa, Japan.
- Department of Respiratory Medicine, Kanazawa University, Kanazawa, Japan.
- Department of Radiology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
- Department of Medical Oncology, Kanazawa University Hospital, Kanazawa, Japan.
ORCID-Profile: Hiroko Ikeda, Seiichi Kakegawa, Keishi Mizuguchi, Seiji Yano, Tomohiro Kobayashi, Satoshi Kobayashi, Akihiro Nishiyama
Zitieren
APA
Ikeda, H., Kakegawa, S., Saito, D., Kinoshita, K., Ito, A., Mizuguchi, K., Yano, S., Kobayashi, T., Kobayashi, S., Nishiyama, A., Takeuchi, S., & Matsumoto, I. (2026). Primary Bronchial Hybrid Low‐Grade Fibromyxoid Sarcoma/Sclerosing Epithelioid Fibrosarcoma With EWSR1::CREB3L1 Fusion: Diagnostic Insights From a Challenging Case in the Respiratory Tract. Pathology International. https://doi.org/10.1111/pin.70185
Vancouver
Ikeda H, Kakegawa S, Saito D, Kinoshita K, Ito A, Mizuguchi K, et al. Primary Bronchial Hybrid Low‐Grade Fibromyxoid Sarcoma/Sclerosing Epithelioid Fibrosarcoma With EWSR1::CREB3L1 Fusion: Diagnostic Insights From a Challenging Case in the Respiratory Tract. Pathology International. 2026. doi:10.1111/pin.70185
BibTeX
@article{Ikeda2026,
author = {Ikeda, Hiroko and Kakegawa, Seiichi and Saito, Daisuke and Kinoshita, Keita and Ito, Ayumi and Mizuguchi, Keishi and Yano, Seiji and Kobayashi, Tomohiro and Kobayashi, Satoshi and Nishiyama, Akihiro and Takeuchi, Shinji and Matsumoto, Isao},
title = {Primary Bronchial Hybrid Low‐Grade Fibromyxoid Sarcoma/Sclerosing Epithelioid Fibrosarcoma With EWSR1::CREB3L1 Fusion: Diagnostic Insights From a Challenging Case in the Respiratory Tract},
journal = {Pathology International},
year = {2026},
doi = {10.1111/pin.70185}
}
EUVIMED